(Q44861697)

English

A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia

scientific article published in April 2004

Statements

A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit